Improvement of Cerebral Blood Flow by Olprinone, a Phosphodiesterase-3 Inhibitor, in Mild Heart Failure

Publisher： Karger

E-ISSN： 1421-9786|16|4|396-401

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.16, Iss.4, 2003-09, pp. : 396-401

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effects of Olprinone, a Phosphodiesterase 3 Inhibitor, on Systemic and Cerebral Circulation

By  

Current Vascular Pharmacology, Vol. 4, Iss. 1, 2006-01 ,pp. : 1-7

Bentham Science Publishers

Access to resources Recommend Favorite

The Management of Phosphodiesterase-5 (PDE5) Inhibitor Failure

By  

Current Vascular Pharmacology, Vol. 4, Iss. 2, 2006-04 ,pp. : 89-93

Bentham Science Publishers

Access to resources Recommend Favorite

Visualization of blood flow with echocardiography: the future for heart failure diagnosis

By Amaki Makato   Abe Haruhiko   Sengupta Partho P  

Interventional Cardiology, Vol. 4, Iss. 6, 2012-12 ,pp. : 609-611

Future Medicine

Access to resources Recommend Favorite

Asymmetric Cerebral Blood Flow in Patients with Mild Cognitive Impairment: Possible Relationship to Further Cognitive Deterioration

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-07 ,pp. : 228-236

Karger

Access to resources Recommend Favorite

Effect of Visit‐to‐Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) Trial

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 2, 2016-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite